You searched for "Nasal"
EROC 2025
Professor Hesham Negm, Faculty of Medicine, Cairo University The 14th edition of the Emirates Rhinology & Otology Conference (EROC) Global Forum 2025 concluded successfully, drawing over 3056 delegates from more than 120 countries and featuring more than 100 distinguished international...Global health missions – not just for consultants. A guide for trainees.
Lulu Ritchie is a courageous and driven trainee in London, inspired by humanitarian missions but conscious of the usual requests for consultant level doctors. Lulu didn’t let that hold her back. She found a way and has kindly summarised her...
Management of the neck in maxillary sinus carcinomas
Primary malignant tumours of the sinonasal tract account for less than 10% of head and neck cancers, of which the maxilla is the second most common subsite and squamous cell carcinoma (SCC) is the most prevalent histological type. Maxillary SCCs...
What is the prognostic value of lymph node yield and density in head and neck cancer?
Neck dissection in addition to surgery of the primary site is commonly recommended in head and neck cancer treatment. However, there has been no consensus on the number of nodes that need to be removed to constitute a sufficient neck...
Variability in the management of differentiated thyroid cancer (DTC)
This retrospective study analyses for the first time the management planning of thyroid surgeons across the specialties. A questionnaire was sent to members of ENT-UK, the British Association of Endocrine and Thyroid Surgeons, Association of Surgeons of Great Britain and...
Dysphagia in people with HPV-related oropharyngeal cancer
Human papilloma virus (HPV) associated oropharyngeal cancers are becoming much more prevalent and, in some geographic areas, have overtaken tobacco as the leading cause of oropharyngeal cancer. HPV-associated cancers are also reported to have better prognosis in general, and research...
Adjuvant radiotherapy for locally advanced (T3–4) major salivary gland cancer – survival benefits quantified
Complete surgical excision of major salivary gland cancers (MSGCs) is the current mainstay of curative treatment for this disease. Indications for postoperative radiotherapy according to current UK national guidelines include high-grade tumours, advanced-stage (stage 3–4) tumours, involved resection margins, perineural...
